STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about BYFC
Insiders, 180 days
-$155.3K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Broadway Financial Corp DE insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, BROADWAY FINANCIAL CORP DE insiders sold a net $155.3K of stock across 35 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BYFC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Mr. Argrett
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$908.5K
$910.0K
$412.8K
-63%
n/a
2023
$1.0M
$973.0K
$438.4K
-63%
n/a
2022
$1.0M
$961.3K
$427.6K
-56%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $155.3K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$188.0K
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BYFC
FY Dec 2025
$184.0K
FY Dec 2024
$155.0K
FY Dec 2023
$179.0K
FY Dec 2022
$145.0K
FY Dec 2021
$249.0K
Jun 2026
$44.0K
Mar 2026
$44.0K
Dec 2025
$53.0K
Sep 2025
$47.0K
Jun 2025
$41.0K
Mar 2025
$43.0K
Dec 2024
$41.0K
Sep 2024
$36.0K
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$6.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BYFC
FY Dec 2025
-$13.0K
FY Dec 2024
$1.3M
FY Dec 2023
$7.4M
FY Dec 2022
$6.0M
FY Dec 2021
-$514.0K
Jun 2026
$3.7M
Mar 2026
$1.1M
Dec 2025
-$2.4M
Sep 2025
$3.7M
Jun 2025
$3.0M
Mar 2025
-$4.4M
Dec 2024
-$2.9M
Sep 2024
$6.1M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-7.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BYFC
FY Dec 2025
-9.1%
FY Dec 2024
+0.7%
FY Dec 2023
+1.5%
FY Dec 2022
+2.7%
FY Dec 2021
-4.3%
Jun 2026
-7.6%
Mar 2026
-7.7%
Dec 2025
-9.1%
Sep 2025
-8.9%
Jun 2025
-0.0%
Mar 2025
-0.2%
Dec 2024
+0.7%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-1.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BYFC
FY Dec 2025
-1.9%
FY Dec 2024
+0.1%
FY Dec 2023
+0.3%
FY Dec 2022
+0.5%
FY Dec 2021
-0.5%
Jun 2026
-1.5%
Mar 2026
-1.6%
Dec 2025
-1.9%
Sep 2025
-1.8%
Jun 2025
-0.0%
Mar 2025
-0.0%
Dec 2024
+0.1%
Sep 2024
+0.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing BYFC
FY Dec 2025
n/a
FY Dec 2024
228.33x
FY Dec 2023
13.86x
FY Dec 2022
23.09x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
228.33x
Sep 2024
24.77x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing BYFC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
0.35x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BYFC ranks highest on growth (81st percentile) and risk and compliance (68th), and lowest on profitability (2nd), among Banks peers.
Profitability
2
Inputs
Return on equity-7.6% · 3 pct, sector of 327
Return on assets-1.5% · 1 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
81
Inputs
Revenue growth, YoY+18.7% · 81 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
27
Inputs
Net Form 4 buying (codes P and S), 180d-$155K · 54 pct, sector of 273
Insider buyers, 180d0 · 0 pct, sector of 273
Risk and compliance
68
Inputs
Short interest, % of float+0.2% · 83 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+11.3% · 53 pct, sector of 127
3 not measured: Financial health, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BYFC filings, in plain words
Are Broadway Financial Corp DE insiders buying or selling BYFC?
In the 180 days to 2026-10-28, Broadway Financial Corp DE insiders were net sellers, a net $155.3K across purchases and sales reported on Form 4, by 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Broadway Financial Corp DE insiders were net sellers of BYFC, a net $155.3K across purchases and sales reported on Form 4 by 2 sellers. None of the 22 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.